## Abstract Exposed surface glycoproteins of resting and __in vitro__ activated human T lymphocytes and leukemic T‐cell lines were labelled by the galactose oxidase‐tritiated sodium borohydride method. The labelled glycoproteins were separated by polyacrylamide slab gel electrophoresis and visualiz
Different surface glycoprotein patterns on human T-, B- and leukemic-lymphocytes
✍ Scribed by Lief C. Andersson; Curt Wasastjerna; Carl G. Gahmberg
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- French
- Weight
- 607 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have labeled the exposed surface glycoprotein of human blood T‐ and B‐lymphocytes and cells from patients with chronic lymphocytic leukemia by the galactose oxidase‐tritiated sodium borohydride method. The labeled glycoproteins were separated by polyacrylamide slab gel electrophoresis and visualized by autoradiography. The T‐ and B‐lymphocytes show different and characteristic surface glycoprotein patterns. The surface glcoprotein patterns of the leukemic cells differ from those of normal, non‐malignant lymphocytes. A relationship between the altered surface glycoprotein pattern of leukemic cells and the expression of leumemiaassociated antigens is discussed.
📜 SIMILAR VOLUMES
Background: In a previous work, we demonstrated with flow cytometry (FCM) methods that accumulation of human cyclin B1 in leukemic cell lines begins during the G 1 phase of the cell cycle (Viallard et al., Exp Cell Res 247: 208-219, 1999). In the present study, FCM was used to compare the localizati
## Abstract A series of 4 cell surface marker systems have been developed and applied to human thymus, tonsil and purified blood lymphocyte populations. Double fluorochrome and mixed fluorochrome‐rosette tests were used to determine cellular specificity and interrelationship of cells bearing the di
## Abstract The monoclonal antibodies, anti‐T1 and anti‐T3, both react with all human peripheral thymus‐derived lymphocytes and with 10% of thymocytes; each, however, recognizes different cell surface structures. It was determined that the target antigen of anti‐T1 is a 69000 molecular weight cell